1. Home
  2. MDAI vs CCEL Comparison

MDAI vs CCEL Comparison

Compare MDAI & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Spectral AI Inc.

MDAI

Spectral AI Inc.

N/A

Current Price

$1.52

Market Cap

48.0M

Sector

Health Care

ML Signal

N/A

Logo Cryo-Cell International Inc.

CCEL

Cryo-Cell International Inc.

N/A

Current Price

$4.97

Market Cap

41.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MDAI
CCEL
Founded
2013
1989
Country
United States
United States
Employees
65
N/A
Industry
Medical/Dental Instruments
Managed Health Care
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
48.0M
41.8M
IPO Year
2021
2022

Fundamental Metrics

Financial Performance
Metric
MDAI
CCEL
Price
$1.52
$4.97
Analyst Decision
Analyst Count
0
0
Target Price
★ $5.11
N/A
AVG Volume (30 Days)
★ 110.0K
11.6K
Earning Date
11-10-2026
10-09-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 65.88
N/A
EPS
N/A
★ 0.23
Revenue
$19,650,000.00
★ $25,384,279.00
Revenue This Year
N/A
N/A
Revenue Next Year
$74.98
N/A
P/E Ratio
★ N/A
$22.04
Revenue Growth
N/A
★ 9.76
52 Week Low
$1.18
$2.72
52 Week High
$2.97
$5.45

Technical Indicators

Market Signals
Indicator
MDAI
CCEL
Relative Strength Index (RSI) 43.00 54.73
Support Level $1.42 $3.05
Resistance Level $1.48 $5.45
Average True Range (ATR) 0.07 0.31
MACD -0.01 -0.00
Stochastic Oscillator 36.00 52.42

Price Performance

Historical Comparison
MDAI
CCEL

About MDAI Spectral AI Inc.

Spectral AI Inc is an AI company focused on predictive medical diagnostics. Its DeepView System uses proprietary AI algorithms to distinguish between fully damaged, partially damaged and healthy human tissue characters invisible to the naked eye, at the initial time point of wound presentation. The DeepView System delivers a binary prediction on the wound's capacity to heal or not-heal by a specified time point in the future. The company focuses on the burn indication which is supported by the BARDA PBS contract.

About CCEL Cryo-Cell International Inc.

Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.

Share on Social Networks: